Alliancebernstein L.P. Exact Sciences Corp Transaction History
Alliancebernstein L.P.
- $290 Billion
- Q2 2025
A detailed history of Alliancebernstein L.P. transactions in Exact Sciences Corp stock. As of the latest transaction made, Alliancebernstein L.P. holds 73,256 shares of EXAS stock, worth $4.74 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
73,256
Previous 69,411
5.54%
Holding current value
$4.74 Million
Previous $3 Million
29.56%
% of portfolio
0.0%
Previous 0.0%
Shares
32 transactions
Others Institutions Holding EXAS
# of Institutions
659Shares Held
158MCall Options Held
1.43MPut Options Held
2.35M-
Capital World Investors Los Angeles, CA18.2MShares$1.18 Billion0.15% of portfolio
-
Vanguard Group Inc Valley Forge, PA17.9MShares$1.16 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$781 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA12MShares$777 Million0.12% of portfolio
-
State Street Corp Boston, MA5.38MShares$348 Million0.01% of portfolio
About EXACT SCIENCES CORP
- Ticker EXAS
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 176,960,000
- Market Cap $11.4B
- Description
- Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...